#Greece #Athens #FAMAR Group #Riku Rautsola #Konstantinos Rengis

FAMAR Group Appoints New CEO

On September 29, 2025, FAMAR Group made a significant leadership change, announcing that Dr. Riku Rautsola would replace Konstantinos Rengis as CEO. Rengis, who had dedicated 16 years to the company, including four years as CEO, decided to step down for personal reasons.

Rengis leaves behind a legacy recognized for prioritizing customer satisfaction and having a comprehensive understanding of the pharmaceutical sector. His tenure was marked by successful navigation through various ownership transitions, enhancements in company operations, and a vision centered on sustainable growth.

Amidst these shifting leadership dynamics, Dr. Riku Rautsola is set to step into the role on the same day, bringing a wealth of experience from his previous roles in the pharmaceutical and biotechnology markets. Before his appointment, Rautsola served on FAMAR's Board of Directors and provided advisory support during the company's acquisition by MidEuropa last year. His prior executive positions demonstrate a strong track record of driving profitable growth in several leading organizations within the industry.

Rautsola stated his commitment to FAMAR's mission of improving production capacity and deepening relationships with global customers. His strategic initiatives also include investing in human resources and enhancing development partnerships. Additionally, Rautsola will maintain his position on the Board of Directors.

Konstantinos Rengis, while transitioning, will continue to support FAMAR in a senior advisory role. His focus will shift towards maintaining strategic relationships with customers and promoting engagement throughout the organization.

Matthew Strassberg, a partner at MidEuropa, expressed gratitude for Rengis' contributions and welcomed Rautsola into his new role, highlighting the promising future that lies ahead for FAMAR under his leadership.

About FAMAR Group

FAMAR is among Europe's top providers of pharmaceutical and cosmetic manufacturing services, boasting a robust legacy that spans over 75 years. With operational facilities located in Spain, Italy, and Greece, the company employs over 1,850 individuals across six production sites and two R&D centers. FAMAR takes pride in delivering over 1,700 different products, servicing more than 80 international markets with a commitment to quality and innovation.

As the company transitions into this next chapter, under Dr. Riku Rautsola’s guidance, it aims to advance both its operational capabilities and capacity to meet the growing demands of the market. The organization looks forward to leveraging Rautsola's extensive experience to enhance its service offerings and foster a culture of continuous improvement and adaptation.